TickerFactsScreenerDevelopers

Aclaris Therapeutics, Inc. (ACRS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$2.19M2013: -$9.16M2014: -$20.75M2015: $92.52M2016: $169.49M2017: $225.26M2018: $215.12M2019: $69.91M2020: $37.65M2021: $197.34M2022: $197.62M2023: $157.18M2024: $155.55M2025: $103.08M$103.08M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$103.08M-33.7%
2024$155.55M-1.0%
2023$157.18M-20.5%
2022$197.62M+0.1%
2021$197.34M+424.1%
2020$37.65M-46.1%
2019$69.91M-67.5%
2018$215.12M-4.5%
2017$225.26M+32.9%
2016$169.49M+83.2%
2015$92.52M+545.8%
2014-$20.75M-126.5%
2013-$9.16M-318.4%
2012-$2.19M—